The U.S. has approved the first vaccine for RSV, shots to protect older adults.
on Wednesday, shots to protect older adults against a respiratory virus that’s most notorious for attacking babies but endangers their grandparents, too.
After decades of failure in the quest for an RSV vaccine, doctors are anxious to finally have something to offer — especially after a virus surge that strained hospitals last fall. FILE - Scanning electron micrograph of human respiratory syncytial virus virions and labeled with anti-RSV F protein/gold antibodies shedding from the surface of human lung epithelial A549 cells.
RSV is a cold-like nuisance for most people but it can be life-threatening for the very young, the elderly and people with certain high-risk health problems. It can impede babies’ breathing by inflaming their tiny airways, or creep deep into seniors’ lungs to cause pneumonia. GSK’s new vaccine for older adults trains the immune system to recognize a protein on RSV’s surface, and contains an ingredient called an adjuvant to further rev up that immune reaction.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
1st RSV vaccine for older adults in US cleared by FDA in historic approvalThe U.S. Food and Drug Administration has approved the first RSV vaccine in the U.S.
Les mer »
In historic approval, FDA clears 1st RSV vaccine for older adults in USThe U.S. Food and Drug Administration has approved the first RSV vaccine in the U.S.
Les mer »
After decades of attempts, FDA approves 1st vaccine for RSVAfter decades of scientific research, the first vaccine for respiratory syncytial virus (RSV), designed to protect older adults, has been approved by the United States.
Les mer »
FDA approves world's first RSV vaccine, a shot for adults ages 60 and upBREAKING: FDA approves the world's first respiratory syncytial virus, or RSV, vaccine made by pharmaceutical giant GSK.
Les mer »
FDA approves first vaccine for RSV, a moment six decades in the making | CNNAfter a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV -- and more are on the way.
Les mer »